exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
vertex and crispr therapeutics present new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) at the 2022 european hematology association (eha) congress #stockmarket #stocks
#Stocks News Feed provides Stock Market News, and Press Releases from several sources in one feed. As an affiliate, we earn from qualifying purchases.